Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Chaoju Eye Care Holdings Ltd. ( (HK:2219) ) just unveiled an update.
Chaoju Eye Care Holdings reported that all resolutions at its 12 May 2026 annual general meeting were passed by poll, with 693,002,501 shares entitled to vote after excluding shares held under its award scheme and shares earmarked for cancellation. All directors attended the meeting in person or electronically, and an independent registrar acted as scrutineer to oversee the vote-taking process.
Shareholders approved the adoption of the company’s audited financial statements for the year ended 31 December 2025 and endorsed a final dividend of HK$0.2423 per share. They also backed the re-election of several executive and independent non-executive directors, authorized the board to set directors’ remuneration, and renewed Ernst & Young as auditor with the board mandated to determine the audit fee.
More about Chaoju Eye Care Holdings Ltd.
Chaoju Eye Care Holdings Ltd. is a Hong Kong-listed medical services provider focused on ophthalmic care. The group operates eye care hospitals and clinics, offering diagnosis, treatment, and surgical services for vision and eye diseases across its regional network.
Average Trading Volume: 485,329
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.04B
For detailed information about 2219 stock, go to TipRanks’ Stock Analysis page.